scispace - formally typeset
A

Anna Zielińska

Researcher at Medical University of Łódź

Publications -  22
Citations -  268

Anna Zielińska is an academic researcher from Medical University of Łódź. The author has contributed to research in topics: Internal medicine & Pinealocyte. The author has an hindex of 6, co-authored 19 publications receiving 103 citations. Previous affiliations of Anna Zielińska include University of Silesia in Katowice.

Papers
More filters
Journal ArticleDOI

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.

TL;DR: This review summarizes recent data on the role of microbiota-gut-brain axis in the pathophysiology of neuropsychiatric and neurological disorders including depression, anxiety, schizophrenia, autism spectrum disorders, Parkinson's disease, migraine, and epilepsy.
Journal ArticleDOI

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain.

TL;DR: There is no one standardized method of managing chronic visceral pain in IBD, so future development, focusing primarily on alleviating the pain, but also on reducing inflammation, is essential.
Journal Article

Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction.

TL;DR: Melatonin increased GAG content in the myocardium remote to infarction and was dependent on the direct influence of the pineal indole on the heart fibroblasts, indicating a direct effect of this indole.
Journal Article

Effect of superior cervical ganglionectomy on the ultrastructure of pinealocytes in the Djungarian hamster (Phodopus sungorus): quantitative study.

TL;DR: Deprivation of sympathetic innervation leads in Djungarian hamsters not only to suppression of melatonin synthesis and secretions but, as appears from studies, induces also morphological changes suggesting lower metabolic and secretory activity of pinealocytes.
Journal ArticleDOI

Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases.

TL;DR: In this article, the authors summarized the current knowledge about chitinases, particularly in IBDs, and demonstrate that they can serve as prognostic biomarkers of disease progression.